Forte Biosciences, Inc. (FBRX) Share-based Payment Arrangement, Expense USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Forte Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • Forte Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $805 K, a 8.21% decline year-over-year.
  • Forte Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.21 M, a 16.3% decline year-over-year.
  • Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.28 M, a 18.2% decline from 2022.
  • Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.02 M, a 4.72% decline from 2021.
  • Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.21 M, a 341% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.21 M $805 K -$72 K -8.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $3.28 M $780 K -$80 K -9.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $3.36 M $772 K -$134 K -14.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.5 M $855 K -$339 K -28.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $3.84 M $877 K -$178 K -16.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $4.02 M $860 K -$378 K -30.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $4.39 M $906 K -$567 K -38.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $4.96 M $1.19 M +$186 K +18.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.77 M $1.06 M +$560 K +113% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $4.21 M $1.24 M +$683 K +123% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.53 M $1.47 M +$1.1 M +293% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.43 M $1.01 M +$984 K +4100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.45 M $495 K +$493 K +24650% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $956 K $555 K +$2.52 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$1.57 M $375 K +$373 K +18650% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$1.94 M $24 K +$23 K +2300% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.96 M $2 K -$2 M -99.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $36 K -$1.97 M -$3.72 M -212% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $3.75 M $2 K -$1.93 M -99.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.68 M $1 K* -$1.67 M -99.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $7.35 M $2 M +$479 K +31.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $6.87 M $1.75 M +$375 K +27.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $6.5 M $1.93 M +$436 K +29.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $6.06 M $1.67 M +$616 K +58.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $5.44 M $1.52 M +$992 K +188% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $4.45 M $1.38 M +$972 K +241% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $3.48 M $1.49 M +$1.18 M +372% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.3 M $1.06 M +$717 K +212% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.59 M $529 K +$264 K +99.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $1.32 M $403 K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $316 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $339 K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $265 K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.